The warfarin‐sulfinpyrazone interaction: stereochemical considerations

Clinical Pharmacology & Therapeutics

Volumn 39, Issue 1, 1986, Pages 15-24

  Toon, Stephen ^a,b,c   Low, Lawrence K ^a,b,c   Gibaldi, Milo ^a,b,c   Trager, William F ^a,b,c   O'Reilly, Robert A ^a,b,c   Motley, Catherine H ^a,b,c   Goulart, Darklis A ^a,b,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDROXYWARFARIN; 7 HYDROXYWARFARIN; 8 HYDROXYWARFARIN; CYTOCHROME P450; HYDROXYWARFARIN; SULFINPYRAZONE; UNCLASSIFIED DRUG; WARFARIN; WARFARIN C 12; WARFARIN C 13; WARFARIN C 14;

ADVERSE DRUG REACTION; ARTICLE; DRUG CLEARANCE; DRUG INTERACTION; DRUG METABOLISM; HUMAN; HUMAN EXPERIMENT; HYPOPROTHROMBINEMIA; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; PROTHROMBIN BLOOD LEVEL; STEREOCHEMISTRY; STEREOISOMERISM; THERAPY;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BLOOD COAGULATION; CARBON ISOTOPES; DRUG INTERACTIONS; FECES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HALF-LIFE; HUMANS; KINETICS; MALE; PROTHROMBIN TIME; STEREOISOMERISM; SULFINPYRAZONE; WARFARIN;

EID: 0022655468     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.1986.3     Document Type: Article

References (0)